Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Beneficial Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life

NCT06759077 is registered in ClinicalTrials.gov with Al-Azhar University as lead sponsor.

NCT NCT06759077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Beneficial Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life
Lead sponsor
Al-Azhar University
Phase
Phase 3
Overall status
Completed
Start date
February 1, 2025
Completion date
April 28, 2026
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases